Literature DB >> 16968943

Prevalence and species distribution of E. Histolytica and E. Dispar in the Venda region, Limpopo, South Africa.

Amidou Samie1, Larry C Obi, Pascal O Bessong, Suzanne Stroup, Eric Houpt, Richard L Guerrant.   

Abstract

The prevalence and species distribution of Entamoeba histolytica and E. dispar in the Venda region were determined in stool samples collected from public hospitals and primary schools by ELISA and a nested polymerase chain reaction (PCR). E. histolytica was detected in 37/197 (18.8%) and 1/47 (2.1%) samples, whereas 50/197 (25.3%) and 4/47 (8.5%) had E. dispar in the hospitals and schools, respectively. The age groups most infected were 0-2 (33%) years followed by 20-29 years (27%). E. histolytica was significantly associated with diarrhea (77.4% versus 22.6%; chi 2 = 39.48, P < 0.05), and with the presence of lactoferrin (85.7% versus 14.2%) in the stools, indicating intestinal inflammation (chi 2 = 29.605, P < 0.05). E. histolytica was found in 5 (16.12%) of the 31 HIV-positive individuals and in 33 (15.5%) of the 213 HIV-negative individuals. E. histolytica infections are common in the Venda region and are associated with diarrhea and intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16968943

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  17 in total

1.  Association between TNF-alpha and Entamoeba histolytica diarrhea.

Authors:  Kristine M Peterson; Jianfen Shu; Priya Duggal; Rashidul Haque; Dinesh Mondal; William A Petri
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

2.  Entamoeba Species in South Africa: Correlations With the Host Microbiome, Parasite Burdens, and First Description of Entamoeba bangladeshi Outside of Asia.

Authors:  Renay Ngobeni; Amidou Samie; Shannon Moonah; Koji Watanabe; William A Petri; Carol Gilchrist
Journal:  J Infect Dis       Date:  2017-12-19       Impact factor: 5.226

Review 3.  The population genetics of commensal Escherichia coli.

Authors:  Olivier Tenaillon; David Skurnik; Bertrand Picard; Erick Denamur
Journal:  Nat Rev Microbiol       Date:  2010-03       Impact factor: 60.633

4.  Seroprevalence of Entamoeba histolytica infection in China.

Authors:  Bin Yang; Yingdan Chen; Liang Wu; Longqi Xu; Hiroshi Tachibana; Xunjia Cheng
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

5.  Molecular epidemiology of amebiasis.

Authors:  Ibne Karim M Ali; C Graham Clark; William A Petri
Journal:  Infect Genet Evol       Date:  2008-05-14       Impact factor: 3.342

6.  Prospective case-control study of the association between common enteric protozoal parasites and diarrhea in Bangladesh.

Authors:  Rashidul Haque; Dinesh Mondal; Anwarul Karim; Imarot Hossain Molla; Abdur Rahim; Abu S G Faruque; Nooruddin Ahmad; Beth D Kirkpatrick; Eric Houpt; Cynthia Snider; William A Petri
Journal:  Clin Infect Dis       Date:  2009-05-01       Impact factor: 9.079

7.  Microsporidiosis in South Africa: PCR detection in stool samples of HIV-positive and HIV-negative individuals and school children in Vhembe district, Limpopo Province.

Authors:  A Samie; C L Obi; S Tzipori; L M Weiss; R L Guerrant
Journal:  Trans R Soc Trop Med Hyg       Date:  2007-04-06       Impact factor: 2.184

8.  Antiamoebic drugs for treating amoebic colitis.

Authors:  Maria Liza M Gonzales; Leonila F Dans; Juliet Sio-Aguilar
Journal:  Cochrane Database Syst Rev       Date:  2019-01-09

9.  Spatial distribution of diarrhoea and microbial quality of domestic water during an outbreak of diarrhoea in the Tshikuwi community in Venda, South Africa.

Authors:  Pascal O Bessong; John O Odiyo; Justice N Musekene; Abera Tessema
Journal:  J Health Popul Nutr       Date:  2009-10       Impact factor: 2.000

Review 10.  Management strategies in the treatment of neonatal and pediatric gastroenteritis.

Authors:  Simona Ciccarelli; Ilaria Stolfi; Giuseppe Caramia
Journal:  Infect Drug Resist       Date:  2013-10-29       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.